PALATIN TECHNOLOGIES INC
PTN$26M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCRANBURY
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
PTN News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Bremelanotide
Kidney Disease
Vehicle Ophthalmic Solution
Dry Eye
tirzepatide
Obesity
PL3994
Hypertension
PL8177
Ulcerative Colitis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Bremelanotide | Phase 3 | Kidney Disease | - | - |
Vehicle Ophthalmic Solution | Phase 3 | Dry Eye | - | - |
tirzepatide | Phase 2 | Obesity | - | - |
PL3994 | Phase 2 | Hypertension | - | - |
PL8177 | Phase 2 | Ulcerative Colitis | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply